Publications
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
July 2023
¿Afecta la obesidad a la respuesta al tratamiento con secukinumab y a su supervivencia en la espondilitis anquilosante? Datos reales del Registro TURKBIO
Mod Rheumatol.2023 doi 10.1093/mr/road061 Epub ahead of print
This observational study suggested that obesity did not affect secukinumab treatment response and drug retention in AS patients.